---
figid: PMC5589569__oncotarget-08-54149-g007
figlink: /pmc/articles/PMC5589569/figure/F7/
number: F7
caption: (A) Following a variety of stimuli that remain to be better delineated (stressors?
  Signaling pathways?), HSF1 is induced in liver cancer cells, where it sustains the
  activation of the PI3K/AKT/mTOR cascade. This leads to metabolic reprogramming of
  liver cancer cells, due to the induction of de novo lipogenesis and glycolysis,
  which support their unconstrained proliferation and survival. (B) Inactivation of
  HSF1 by overexpression of a dominant negative form (HSF1dn) or specific inhibitors
  results in the suppression of the PI3K/AKT/mTOR pathway, thus inhibiting aberrant
  lipogenesis and glycolysis with consequent apoptosis and growth restraint of liver
  cancer cells.
pmcid: PMC5589569
papertitle: Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines
  in vitro and AKT-driven hepatocarcinogenesis in mice.
reftext: Antonio Cigliano, et al. Oncotarget. 2017 Aug 15;8(33):54149-54159.
pmc_ranked_result_index: '1978'
pathway_score: 0.6974648
filename: oncotarget-08-54149-g007.jpg
figtitle: Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in
  vitro and AKT-driven hepatocarcinogenesis in mice
year: '2017'
organisms:
- Mus musculus
- Diaporthe sclerotioides
- Armoracia rusticana
- Homo sapiens
- Bos taurus
- Capra hircus
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5589569__oncotarget-08-54149-g007.html
  '@type': Dataset
  description: (A) Following a variety of stimuli that remain to be better delineated
    (stressors? Signaling pathways?), HSF1 is induced in liver cancer cells, where
    it sustains the activation of the PI3K/AKT/mTOR cascade. This leads to metabolic
    reprogramming of liver cancer cells, due to the induction of de novo lipogenesis
    and glycolysis, which support their unconstrained proliferation and survival.
    (B) Inactivation of HSF1 by overexpression of a dominant negative form (HSF1dn)
    or specific inhibitors results in the suppression of the PI3K/AKT/mTOR pathway,
    thus inhibiting aberrant lipogenesis and glycolysis with consequent apoptosis
    and growth restraint of liver cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - HSF1
  - AKT2
  - PIK3R5
  - AKT1
  - PIK3R6
  - PIK3R3
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - AKT3
  - PIK3CG
genes:
- word: PI3K/AKT/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HSF1
  symbol: HSF1
  source: hgnc_symbol
  hgnc_symbol: HSF1
  entrez: '3297'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals: []
diseases: []
figid_alias: PMC5589569__F7
redirect_from: /figures/PMC5589569__F7
figtype: Figure
---
